COVID-19 vaccines: early success and remaining challenges

被引：26

作者：

Bar-Zeev, Naor ^{[1
]}

Inglesby, Tom ^{[2
]}

机构：

[1] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA

[2] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hlth Secur, Baltimore, MD 21205 USA

来源：

LANCET | 2020年 / 396卷 / 10255期

关键词：

D O I：

10.1016/S0140-6736(20)31867-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：868 / 869

页数：2

共 7 条

[1] Vaccine confidence in the time of COVID-19 [J].

Harrison, Emily A. ;

Wu, Julia W. .

EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2020, 35 (04) :325-330

[2] An mRNA Vaccine against SARS-CoV-2-Preliminary Report [J].

Jackson, L. A. ;

Anderson, E. J. ;

Rouphael, N. G. ;

Roberts, P. C. ;

Makhene, M. ;

Coler, R. N. ;

McCullough, M. P. ;

Chappell, J. D. ;

Denison, M. R. ;

Stevens, L. J. ;

Pruijssers, A. J. ;

McDermott, A. ;

Flach, B. ;

Doria-Rose, N. A. ;

Corbett, K. S. ;

Morabito, K. M. ;

O'Dell, S. ;

Schmidt, S. D. ;

Swanson, P. A. ;

Padilla, M. ;

Mascola, J. R. ;

Neuzil, K. M. ;

Bennett, H. ;

Sun, W. ;

Peters, E. ;

Makowski, M. ;

Albert, J. ;

Cross, K. ;

Buchanan, W. ;

Pikaart-Tautges, R. ;

Ledgerwood, J. E. ;

Graham, B. S. ;

Beigel, J. H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20) :1920-1931

[3] COVID-19 vaccine trials should seek worthwhile efficacy [J].

Krause, Philip ;

Fleming, Thomas R. ;

Longini, Ira ;

Henao-Restrepo, Ana Maria ;

Peto, Richard .

LANCET, 2020, 396 (10253) :741-743

[4] Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines [J].

Lambert, Paul-Henri ;

Ambrosino, Donna M. ;

Andersen, Svein R. ;

Baric, Ralph S. ;

Black, Steven B. ;

Chen, Robert T. ;

Dekker, Cornelia L. ;

Didierlaurent, Arnaud M. ;

Graham, Barney S. ;

Martin, Samantha D. ;

Molrine, Deborah C. ;

Perlman, Stanley ;

Picard-Fraser, Philip A. ;

Pollard, Andrew J. ;

Qin, Chuan ;

Subbarao, Kanta ;

Cramer, Jakob P. .

VACCINE, 2020, 38 (31) :4783-4791

[5] Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia [J].

Logunov, Denis Y. ;

Dolzhikova, Inna V. ;

Zubkova, Olga V. ;

Tukhvatullin, Amir I. ;

Shcheblyakov, Dmitry V. ;

Dzharullaeva, Alina S. ;

Grousova, Daria M. ;

Erokhova, Alina S. ;

Kovyrshina, Anna V. ;

Botikov, Andrei G. ;

Izhaeva, Fatima M. ;

Popova, Olga ;

Ozharovskaya, Tatiana A. ;

Esmagambetov, Ilias B. ;

Favorskaya, Irina A. ;

Zrelkin, Denis I. ;

Voronina, Daria V. ;

Shcherbinin, Dmitry N. ;

Semikhin, Alexander S. ;

Simakova, Yana V. ;

Tokarskaya, Elizaveta A. ;

Lubenets, Nadezhda L. ;

Egorova, Daria A. ;

Shmarov, Maksim M. ;

Nikitenko, Natalia A. ;

Morozova, Lola F. ;

Smolyarchuk, Elena A. ;

Kryukov, Evgeny V. ;

Babira, Vladimir F. ;

Borisevich, Sergei V. ;

Naroditsky, Boris S. ;

Gintsburg, Alexander L. .

LANCET, 2020, 396 (10255) :887-897

[6] The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic [J].

Won, Jung-Hyun ;

Lee, Howard .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) :1-17

[7] Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial [J].

Zhu, Feng-Cai ;

Guan, Xu-Hua ;

Li, Yu-Hua ;

Huang, Jian-Ying ;

Jiang, Tao ;

Hou, Li-Hua ;

Li, Jing-Xin ;

Yang, Bei-Fang ;

Wang, Ling ;

Wang, Wen-Juan ;

Wu, Shi-Po ;

Wang, Zhao ;

Wu, Xiao-Hong ;

Xu, Jun-Jie ;

Zhang, Zhe ;

Jia, Si-Yue ;

Wang, Bu-Sen ;

Hu, Yi ;

Liu, Jing-Jing ;

Zhang, Jun ;

Qian, Xiao-Ai ;

Li, Qiong ;

Pan, Hong-Xing ;

Jiang, Hu-Dachuan ;

Deng, Peng ;

Gou, Jin-Bo ;

Wang, Xue-Wen ;

Wang, Xing-Huan ;

Chen, Wei .

LANCET, 2020, 396 (10249) :479-488

← 1 →